Clover Biopharmaceuticals, Ltd. (HKG:2197)
0.2090
+0.0030 (1.46%)
Apr 25, 2025, 3:57 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 271.09 million as of April 25, 2025. Its market cap has decreased by -49.02% in one year.
Market Cap
271.09M
Enterprise Value
-76.24M
Revenue
40.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 271.09M, a decrease of -98.20%. That is a compound annual growth rate of -68.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2025 | 271.09M | -13.28% |
Dec 31, 2024 | 312.59M | -61.08% |
Dec 29, 2023 | 803.26M | -76.01% |
Dec 30, 2022 | 3.35B | -78.71% |
Dec 31, 2021 | 15.73B | 4.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeiGene | 204.71B |
Hansoh Pharmaceutical Group Company | 142.11B |
JD Health International | 114.63B |
WuXi Biologics | 92.39B |
Innovent Biologics | 89.58B |
Akeso | 88.77B |
Alibaba Health Information Technology | 74.78B |
Sino Biopharmaceutical | 70.68B |